相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exercise-induced AMPK activity in skeletal muscle: Role in glucose uptake and insulin sensitivity
Martin Friedrichsen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
The Mitochondrial Pyruvate Carrier: Has It Been Unearthed at Last?
Andrew P. Halestrap
CELL METABOLISM (2012)
Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
I. N. Colmers et al.
DIABETES & METABOLISM (2012)
Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione
Zhouji Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Viral Deubiquitylating Enzyme Restores Dislocation of Substrates from the Endoplasmic Reticulum (ER) in Semi-intact Cells
Sumana Sanyal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Mitochondrial Mystery, Solved
Ajit S. Divakaruni et al.
SCIENCE (2012)
Identification and Functional Expression of the Mitochondrial Pyruvate Carrier
Sebastien Herzig et al.
SCIENCE (2012)
A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans
Daniel K. Bricker et al.
SCIENCE (2012)
Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
Benjamin W. Miller et al.
ANNALS OF PHARMACOTHERAPY (2011)
Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner
Yochai Birnbaum et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
Preservation of β-Cell Function: The Key to Diabetes Prevention
Ralph A. DeFronzo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-γ-Independent Mechanisms
Serge C. Thal et al.
JOURNAL OF NEUROTRAUMA (2011)
Brain fuel metabolism, aging, and Alzheimer's disease
Stephen Cunnane et al.
NUTRITION (2011)
Regulation of intermediary metabolism by protein acetylation
Kun-Liang Guan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Phospholipid Hydrolysis Caused by Clostridium perfringens α-Toxin Facilitates the Targeting of Perfringolysin O to Membrane Bilayers
Paul C. Moe et al.
BIOCHEMISTRY (2010)
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Simon A. Hawley et al.
CELL METABOLISM (2010)
Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
David J. Graham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Energy Restriction as an Antitumor Target of Thiazolidinediones
Shuo Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effects of Pioglitazone on Intramyocellular Fat Metabolism in Patients with Type 2 Diabetes Mellitus
Mandeep Bajaj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi et al.
NATURE (2010)
Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial
D. K. Coletta et al.
DIABETOLOGIA (2009)
Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes
Marta Rubio et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus
Tetsuya Teranishi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration
Sashi Nadanaciva et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Pharmacokinetics and pharmacodynamics of rosiglitazone in elation to CYP2C8 genotype
Julia Kirchheiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects
Gautam K. Bandyopadhyay et al.
DIABETES (2006)
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues
Nathan K. LeBrasseur et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
A Natali et al.
DIABETOLOGIA (2006)
Excitotoxic injury to mitochondria isolated from cultured neurons
YE Kushnareva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
DL Feinstein et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARγ agonists
BS Cha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier
JCW Hildyard et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2005)
AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome
N Ruderman et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Thiazolidinediones, like metformin, inhibit respiratory complex I -: A common mechanism contributing to their antidiabetic actions?
B Brunmair et al.
DIABETES (2004)
Identification of a novel mitochondrial protein (mitoNEET) cross-linked specifically by a thiazolidinedione photoprobe
JR Colca et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones
AW Norris et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Impaired mitochondrial pyruvate importation in a patient and a fetus at risk
M Brivet et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Peroxisome proliferator-activated receptor γ thiazolidinedione agonists increase glucose metabolism in astrocytes
C Dello Russo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
LGD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Clinical pharmacokinetics of pioglitazone
DA Eckland et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2000)
分享论文
